This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring both an aminopiperidine moiety and a fluorophenyl group, makes it valuable in the development of compounds targeting neurological and psychiatric disorders. It is often explored for its potential in creating drugs that interact with specific receptors in the brain, such as dopamine or serotonin receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, its fluorinated aromatic component enhances its metabolic stability, making it a useful building block in the design of bioactive molecules with improved pharmacokinetic properties. Researchers also investigate its role in developing enzyme inhibitors, particularly those involved in neurotransmitter regulation, further underscoring its significance in drug discovery.